153 related articles for article (PubMed ID: 1295765)
1. Value of measurement of C-reactive protein in febrile patients with hematological malignancies.
Rintala E; Irjala K; Nikoskelainen J
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):973-8. PubMed ID: 1295765
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies.
Rintala E
Scand J Infect Dis; 1994; 26(1):77-84. PubMed ID: 8191244
[TBL] [Abstract][Full Text] [Related]
3. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
[TBL] [Abstract][Full Text] [Related]
4. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein levels in the management of infection in acute leukaemia.
Starke ID; de Beer FC; Donnelly JP; Catovsky D; Goldman JM; Galton DA; Pepys MB
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):319-25. PubMed ID: 6584311
[TBL] [Abstract][Full Text] [Related]
6. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein levels in neutropenic patients with pyrexia.
Gozzard DI; French EA; Blecher TE; Powell RJ
Clin Lab Haematol; 1985; 7(4):307-16. PubMed ID: 3830530
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
10. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
11. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer.
Katz JA; Mustafa MM; Bash RO; Cash JV; Buchanan GR
Pediatr Infect Dis J; 1992 Sep; 11(9):708-12. PubMed ID: 1448309
[TBL] [Abstract][Full Text] [Related]
12. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
13. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
14. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
15. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
16. Serial serum C-reactive protein levels in the diagnosis of neonatal infection.
Benitz WE; Han MY; Madan A; Ramachandra P
Pediatrics; 1998 Oct; 102(4):E41. PubMed ID: 9755278
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.
Paran Y; Yablecovitch D; Choshen G; Zeitlin I; Rogowski O; Ben-Ami R; Katzir M; Saranga H; Rosenzweig T; Justo D; Orbach Y; Halpern P; Berliner S
Crit Care; 2009; 13(2):R50. PubMed ID: 19351421
[TBL] [Abstract][Full Text] [Related]
18. Role of C-reactive protein velocity in the diagnosis of early bacterial infections in children after cardiac surgery.
Nahum E; Livni G; Schiller O; Bitan S; Ashkenazi S; Dagan O
J Intensive Care Med; 2012; 27(3):191-6. PubMed ID: 21561990
[TBL] [Abstract][Full Text] [Related]
19. Variation of serum C-reactive protein (CRP) over time in pediatric cancer patients with febrile illness and its relevance to identified pathogen.
Sklavou R; Karavanaki K; Critselis E; Kossiva L; Giannaki M; Tsolia M; Papadakis V; Papargyri S; Vlachou A; Karantonis F; Gourgiotis D; Polychronopoulou S
Clin Biochem; 2012 Oct; 45(15):1178-82. PubMed ID: 22820435
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.
Santolaya ME; Cofre J; Beresi V
Clin Infect Dis; 1994 Apr; 18(4):589-95. PubMed ID: 8038314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
